공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

세계의 종양 바이오시밀러 시장 분석(2021년) : 코로나19(COVID-19)에 의한 성장과 변화(-2030년)

Oncology Biosimilars Global Market Report 2021: COVID-19 Growth And Change To 2030

리서치사 The Business Research Company
발행일 On Demand Report 상품 코드 1028798
페이지 정보 영문 175 Pages
가격
US $ 5,000 ₩ 5,987,000 PDF (Single User License)
US $ 7,500 ₩ 8,981,000 PDF (Site License)
US $ 10,000 ₩ 11,975,000 PDF (Enterprise License)


세계의 종양 바이오시밀러 시장 분석(2021년) : 코로나19(COVID-19)에 의한 성장과 변화(-2030년) Oncology Biosimilars Global Market Report 2021: COVID-19 Growth And Change To 2030
발행일 : On Demand Report 페이지 정보 : 영문 175 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계 종양 바이오시밀러(Oncology Biosimilars) 시장의 구조와 동향에 대해 분석했으며, 시장의 주요 특징과 구조, 전체적인 시장 규모 및 성장률 동향 전망, 약제 유형별·지역별·주요 국가별 상세 동향, 주요 기업 개요, 최근의 주요 동향, 향후 시장 기회 등에 대해 전해드립니다.

목차

제1장 개요

제2장 종양 바이오시밀러 시장의 특징

제3장 종양 바이오시밀러 시장 동향과 전략

제4장 종양 바이오시밀러 시장에 대한 코로나19(COVID-19)의 영향

제5장 종양 바이오시밀러 시장 : 시장 규모 및 성장률

  • 시장 규모(단위 : 10억 달러, 2015-2020년)
    • 시장 성장 촉진요인
    • 시장 성장 억제요인
  • 시장 규모(단위 : 10억 달러, 2020-2025년, 2030년)
    • 시장 성장 촉진요인
    • 시장 성장 억제요인

제6장 종양 바이오시밀러 시장 : 분야별 분석

  • 약제 유형별 시장 규모(단위 : 10억 달러, 2015-2020년/2020-2025년/2030년)
  • 단클론항체
  • 면역조절제
  • 조혈제
  • 과립구 집락자극인자(G-CSF)
  • 암 유형별 시장 규모(단위 : 10억 달러, 2015-2020년/2020-2025년/2030년)
  • 유방암
  • 대장암
  • 혈액암
  • 호중구 감소증
  • 비소세포폐암
  • 기타
  • 유통 유형별 시장 규모(단위 : 10억 달러, 2015-2020년/2020-2025년/2030년)
  • 병원 약국
  • 소매 약국
  • 온라인 약국

제7장 종양 바이오시밀러 시장 : 지역별/국가별 분석

  • 지역별 시장 규모(단위 : 10억 달러, 2015-2020년/2020-2025년/2030년)
  • 국가별 시장 규모(단위 : 10억 달러, 2015-2020년/2020-2025년/2030년)

제8장 아시아태평양의 종양 바이오시밀러 시장

  • 시장 개요
  • 지역 정보
  • 약제 유형별 시장 규모(단위 : 10억 달러, 2015-2020년/2020-2025년/2030년)

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽의 종양 바이오시밀러 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 동유럽의 종양 바이오시밀러 시장

제20장 러시아 시장

제21장 북미의 종양 바이오시밀러 시장

제22장 미국 시장

제23장 남미의 종양 바이오시밀러 시장

제24장 브라질 시장

제25장 중동의 종양 바이오시밀러 시장

제26장 아프리카의 종양 바이오시밀러 시장

제27장 종양 바이오시밀러 시장 : 경쟁 구도와 기업 개요

  • 경쟁 구도
  • 기업 개요
    • Biocoin
    • Celltrion Inc.
    • Dr. Reddy's Laboratories Ltd.
    • Intas Pharmaceuticals Ltd.
    • STADA Arzneimittel AG

제28장 종양 바이오시밀러 파이프라인 제품 분석

제29장 종양 바이오시밀러 시장의 주요 인수합병(M&A)

제30장 종양 바이오시밀러 시장 : 전망과 잠재력 분석

제31장 부록

LSH 21.09.30

“Oncology Biosimilars Global Market Report 2021: COVID-19 Growth And Change to 2030” from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global oncology biosimilars market.

This report focuses on oncology biosimilars market which is experiencing strong growth. The report gives a guide to the oncology biosimilars market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the oncology biosimilars? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The Oncology Biosimilars market global report” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider oncology biosimilars market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The oncology biosimilars market section of the report gives context. It compares the oncology biosimilars market with other segments of the oncology biosimilars market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, oncology biosimilars indicators comparison.

Scope

Markets Covered:

1) By Drug Type: Monoclonal Antibody; Immunomodulators; Hematopoietic Agents; Granulocyte Colony-Stimulating Factor (G-CSF)

2) By Cancer Type: Breast Cancer; Colorectal Cancer; Blood Cancer; Neutropenia Cancer; Non-Small Cell Lung Cancer; Others

3) By Distribution Type: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy

Companies Mentioned: Biocoin; Celltrion Inc.; Dr. Reddy's Laboratories Ltd.; Intas Pharmaceuticals Ltd.; STADA Arzneimittel AG

Countries: Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, UK, USA, Australia

Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, per capita expenditure.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Oncology Biosimilars Market Characteristics

3. Oncology Biosimilars Market Trends And Strategies

4. Impact Of COVID-19 On Oncology Biosimilars

5. Oncology Biosimilars Market Size And Growth

  • 5.1. Global Oncology Biosimilars Historic Market, 2015-2020, $ Billion
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints On The Market
  • 5.2. Global Oncology Biosimilars Forecast Market, 2020-2025F, 2030F, $ Billion
    • 5.2.1. Drivers Of The Market
    • 5.2.2. Restraints On the Market

6. Oncology Biosimilars Market Segmentation

  • 6.1. Global Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Monoclonal Antibody
  • Immunomodulators
  • Hematopoietic Agents
  • Granulocyte Colony-Stimulating Factor (G-CSF)
  • 6.2. Global Oncology Biosimilars Market, Segmentation By Cancer Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Breast Cancer
  • Colorectal Cancer
  • Blood Cancer
  • Neutropenia Cancer
  • Non-Small Cell Lung Cancer
  • Others
  • 6.3. Global Oncology Biosimilars Market, Segmentation By Distribution Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

7. Oncology Biosimilars Market Regional And Country Analysis

  • 7.1. Global Oncology Biosimilars Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 7.2. Global Oncology Biosimilars Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

8. Asia-Pacific Oncology Biosimilars Market

  • 8.1. Asia-Pacific Oncology Biosimilars Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

9. China Oncology Biosimilars Market

  • 9.1. China Oncology Biosimilars Market Overview
  • 9.2. China Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion

10. India Oncology Biosimilars Market

  • 10.1. India Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

11. Japan Oncology Biosimilars Market

  • 11.1. Japan Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

12. Australia Oncology Biosimilars Market

  • 12.1. Australia Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

13. Indonesia Oncology Biosimilars Market

  • 13.1. Indonesia Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

14. South Korea Oncology Biosimilars Market

  • 14.1. South Korea Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

15. Western Europe Oncology Biosimilars Market

  • 15.1. Western Europe Oncology Biosimilars Market Overview
  • 15.2. Western Europe Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

16. UK Oncology Biosimilars Market

  • 16.1. UK Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

17. Germany Oncology Biosimilars Market

  • 17.1. Germany Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

18. France Oncology Biosimilars Market

  • 18.3. France Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

19. Eastern Europe Oncology Biosimilars Market

  • 19.1. Eastern Europe Oncology Biosimilars Market Overview
  • 19.2. Eastern Europe Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

20. Russia Oncology Biosimilars Market

  • 20.1. Russia Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

21. North America Oncology Biosimilars Market

  • 21.1. North America Oncology Biosimilars Market Overview
  • 21.2. North America Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

22. USA Oncology Biosimilars Market

  • 22.1. USA Oncology Biosimilars Market Overview
  • 22.2. USA Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

23. South America Oncology Biosimilars Market

  • 23.1. South America Oncology Biosimilars Market Overview
  • 23.2. South America Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

24. Brazil Oncology Biosimilars Market

  • 24.1. Brazil Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

25. Middle East Oncology Biosimilars Market

  • 25.1. Middle East Oncology Biosimilars Market Overview
  • 25.2. Middle East Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

26. Africa Oncology Biosimilars Market

  • 26.1. Africa Oncology Biosimilars Market Overview
  • 26.2. Africa Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

27. Oncology Biosimilars Market Competitive Landscape And Company Profiles

  • 27.1. Oncology Biosimilars Market Competitive Landscape
  • 27.2. Oncology Biosimilars Market Company Profiles
    • 27.2.1. Biocoin
      • 27.2.1.1. Overview
      • 27.2.1.2. Products and Services
      • 27.2.1.3. Strategy
      • 27.2.1.4. Financial Performance
    • 27.2.2. Celltrion Inc.
      • 27.2.2.1. Overview
      • 27.2.2.2. Products and Services
      • 27.2.2.3. Strategy
      • 27.2.2.4. Financial Performance
    • 27.2.3. Dr. Reddy's Laboratories Ltd.
      • 27.2.3.1. Overview
      • 27.2.3.2. Products and Services
      • 27.2.3.3. Strategy
      • 27.2.3.4. Financial Performance
    • 27.2.4. Intas Pharmaceuticals Ltd.
      • 27.2.4.1. Overview
      • 27.2.4.2. Products and Services
      • 27.2.4.3. Strategy
      • 27.2.4.4. Financial Performance
    • 27.2.5. STADA Arzneimittel AG
      • 27.2.5.1. Overview
      • 27.2.5.2. Products and Services
      • 27.2.5.3. Strategy
      • 27.2.5.4. Financial Performance

28. Oncology Biosimilars Pipeline Analysis

29. Key Mergers And Acquisitions In The Oncology Biosimilars Market

30. Oncology Biosimilars Market Future Outlook and Potential Analysis

31. Appendix

  • 31.1. Abbreviations
  • 31.2. Currencies
  • 31.3. Research Inquiries
  • 31.4. The Business Research Company
  • 31.5. Copyright And Disclaimer
Back to Top
전화 문의
F A Q